P2Y-purinoceptor mediated inhibition of L-type Ca2+ channels in rat pancreatic beta-cells

We used the patch-clamp technique to study the effects of extracellular ATP on the activity of ion channels recorded in rat pancreatic beta -cells. In cell-attached membrane patches, action currents induced by 8.3 mM glucose were inhibited by 0.1 mM ATP, 0.1 mM ADP or 15 muM ADP betaS but not by 0.1 mM AMP or 0.1 mM adenosine. In perforated membrane patches, action potenti als mere measured in current clamp, induced by 8.3 mM glucose, and were als o inhibited by 0.1 mM ATP with a modest hyperpolarization to -43 mV. In who le-cell clamp experiments, ATP dose-dependently decreased the amplitudes of L-type Ca2+ channel currents (ICa) to 56.7 +/- 4.0% (p<0.001) of the contr ol, but did not influence ATP-sensitive K+ channel currents observed in the presence of 0.1 mM ATP and 0.1 mM ADP in the pipette. Agonists of P2Y puri noceptors, 2-methylthio ATP (0.1 mM) or ADP<beta>S (15 muM) mimicked the in hibitory effect of ATP on ICa, but PPADS (0.1 mM) and suramin (0.2 mM), ant agonists of P2 purinoceptors, counteracted this effect. When we used 0.1 mM GTP gammaS in the pipette solution, ATP irreversibly reduced ICa to 58.4 /- 6.6% of the control (p<0.001). In contrast, no inhibitory effect of ATP was observed when 0.2 mM GDP<beta>S was used in the pipette solution. The u se of either 20 mM BAPTA instead of 10 mM EGTA, or 0.1 mM compound 48/80, a blocker of phospholipase C (PLC), in the pipette solution abolished the in hibitory effect of ATP on ICa, but 1 muM staurosporine, a blocker of protei n kinase C (PKC), did not. When the beta -cells were pretreated with 0.4 mu M thapsigargin, an inhibitor of the endoplasmic reticulum (ER) Ca2+ pump, A TP lost the inhibitory effect on ICa. These results suggest that extracellu lar ATP inhibits action potentials by Ca2+-induced ICa inhibition in which an increase in cytosolic Ca2+ released from thapsigargin-sensitive store si tes was brought about by a P2Y purinoceptor-coupled G-protein, PI-PLC and I P3 pathway.